- Tackling challenges in cell therapy study design to reduce timelines and ensure quality and relevance for the field
- Partnering effectively with CROs: what constitutes a productive collaboration in the cell therapy space
- Logistics in cell therapy: challenges and solutions
Archives: Agenda
Beyond outsourcing: Rethinking the CRO-biotech partnership
How strategic collaboration can accelerate innovation:
- Moving from transactional execution to consultative partnership
- How CROs can become strategic problem solvers, not just service providers
- Building trust transparency and shared accountability
KEYNOTE PANEL: Practical considerations for navigating the regulatory landscape of global trials in 2026
- Keeping compliant with evolving global, regional, and local regulation to minimize timelines and avoid costly delays
- Overviewing new regulation and assessing the impact on conducting oncology clinical trials
- Ensuring vendor oversight to ensure regulatory compliance for smooth running of oncology clinical trials
- Considering Project Optimus early in development programs to keep in line with regulatory demands
Registration and refreshments
Chairperson’s opening remarks
PRIVATE DINNER
The AI Advantage in Insurance: Winning On Customer Experience
- Where AI is delivering real CX results
- Reduce churn & boost retention
- Personalised, digital-first journeys
Allan Christian
General Manager
Engage

What strategic investors want in 2027 and how smaller biotechs can compete
- Navigating the VC & strategic investment landscape: Understanding fund priorities, timing, and risk thresholds to position your trial and company for maximum appeal amid intense competition for limited budgets
- Crafting a compelling narrative, highlighting niche advantages, and strengthening your pipeline to secure funding partnerships that bridge financial gaps and accelerate oncology innovation
- How adaptive designs, decentralized elements, synthetic control arms, and AI-driven efficiencies can make oncology studies more capital-efficient and more attractive to venture capital and strategic investors
- Avoiding bankruptcy risk for biotechs with clear early efficacy signals, validated biomarkers and programs with strong regulatory alignment
Traditional segmentation gets you in. Taste makes you win.
- Traditional segmentation still matters—but it’s not enough
- The no-alcohol opportunity is much bigger than it looks
- Who are non-alcohol consumers? Let’s go beyond the surface
- Better taste match directly translates into higher value share
From Closure to Connection: Turning Every Bottle Closure into a Connected Asset
- Connected packaging platform that turns standard closures into digital marketing channels.
- How every bottle cap is already a direct touchpoint with the consumer – and why most brands aren’t using it
- How P-Code works: unique QR codes printed at industrial scale enabling promotions, loyalty mechanics, traceability, and sustainability communication
- Real-world results: lessons from deploying over half a billion coded caps in 2025
- What beverage brands need to get right operationally and technically to activate connected packaging at scale – and what the data reveals about consumer scanning behaviour
Packaging Decisions Drive Business Results
- Driving top line growth through smart can packaging
- Improving efficiency, costs and ESG in kegs
- From technical detail to measurable business results